Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Legal-Bay Lawsuit Settlement Funding to Begin Funding Cases for Plaintiffs involving GranuFlo, Xarelto, and Morcellator Products

Case Funding Firm says they are adding these three litigations to their core funding cases for 2015; company reaffirms their general list of lawsuit settlement funding cases for 2015 as well.


News provided by

Legal-Bay LLC

Jan 19, 2015, 05:00 ET

Share this article

Share toX

Share this article

Share toX

MONTCLAIR, N.J., Jan. 19, 2015 /PRNewswire/ -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, announced today that they have begun to fund cases for plaintiffs involved in GranuFlo, Xarelto, and Morcellator cases. Due to the severity of the potential side effects and complications from using these products, Legal-Bay is focused on aiding patients who are in need of a lawsuit cash advance while their cases are being fought in the court system. Legal-Bay is a leader in emerging mass tort litigation, and while most companies are not funding these cases just yet, Legal-Bay strives to assist victims in the best way they can. Not only can Legal-Bay offer pre-settlement lawsuit funding, but they can also provide assistance in finding a law firm or lawyer if you are unsure whether or not you have a potential claim against any of the manufacturers involved. Legal-Bay is providing information for plaintiffs and potential victims of these products so they can get the free help that they need.

Continue Reading

Logo - http://photos.prnewswire.com/prnh/20140714/126845

Below is an overview of each product as well as the potential side effects and other pertinent information:

  • GranuFlo: GranuFlo and NaturaLyte are chemical dialysis products that are used in dialysis machines for the purpose of helping to clean the blood of the patient with kidney malfunctions. The products are designed to prevent dangerous acid buildup in the kidneys. However, recent lawsuits claim that these ingredients may also increase the patient's risk of having cardiac arrest and/or various cardiovascular problems. Serious side effects include: heart attack, cardiopulmonary arrest, cardiovascular death, and stroke. There are currently over 2,000 cases against Fresenius Medical Care Inc. regarding GranuFlo and NaturaLyte, and they have been consolidated into multidistrict litigation (MDL) in Massachusetts Federal Court under U.S. District Judge Douglas P. Woodlock. The first trial is scheduled for January of 2016 with the following trial set to take place a month later.
  • Xarelto: Xarelto was initially approved in 2011 and is one of the most recent blood thinners on the market. The blood thinner is manufactured by Bayer and is marketed by Johnson & Johnson's subsidiary, Janssen Pharmaceuticals. Dangerous side effects include: internal bleeding, intestinal bleeding, rectal bleeding, blood clots, embolism, brain hemorrhaging, and death caused by uncontrolled bleeding. Hundreds of lawsuits have been filed over blood thinners, including Pradaxa and Xarelto, and have been consolidated into multidistrict litigation (MDL).
  • Morcellators: Morcellators have been used in different laparoscopic surgeries including hysterectomy and myomectomy procedures as well as laparoscopic spleen and renal surgeries. While the morcellator device provides a less-invasive surgery and quicker recovery time, the following have been listed as potential side effects: spread of malignant tissue, advanced-stage cancerous growths, and metastatic leiomyosarcoma, an aggressive uterine cancer.

Patty Kirby, COO and Head of Client Relations, commented on the company's recent focus, "We are pleased to begin accepting applications and funding requests on cases involving GranuFlo, Xarelto, and Morcellators, along with the rest of our target funding cases for 2015. Today's announcement shows our company's willingness to be at the forefront of mass tort litigation lawsuit funding, even though these litigations are still in the very early stages and the defendants continue to defend the claims aggressively.

Legal-Bay is urging users of GranuFlo, Xarelto, or Morcellator products, or family members who have had a loved one injured or deceased as a result, to contact a law firm immediately. Legal-Bay works with nationally recognized lawyers and attorneys who can assist you with obtaining a free legal consultation on your potential lawsuit claim if you have not retained a lawyer yet. To request to speak with a qualified Granuflo, Xarelto or Morcellator lawyer, contact Legal-Bay at: http://lawsuitssettlementfunding.com/contact-us.php

Along with Granuflo, Xarelto, and Morcellator cases, Legal-Bay reaffirms today their general list of lawsuit settlement funding cases for 2015 as well, stating that the cases listed below (as well as others not listed) are eligible for 24 to 48-hour approvals:

Car Accident Funding, Car Wreck Funding, Truck Accident Funding, Airplane Accident/Injury Case Funding, Bicycle Injury/Incident Case Funding, Kugel Mesh Hernia Case Funding, DePuy Hip Lawsuit Funding, Stryker Hip Lawsuit Funding, BP Oil Spill Claim Funding, Construction Accident Funding, Discrimination Case Funding, Medical Malpractice Lawsuit Funding, Pharmaceutical Lawsuit Funding, Yaz or Yasmin Birth Control Case Funding, NuvaRing Funding, Police Brutality Case Funding, Transvaginal Mesh and Bladder Sling Lawsuit Funding, Merrill Lynch Black Broker Settlement Funding, BioMet and Wright Hip Funding, Sexual Harassment and Sexual Abuse Lawsuit Funding, Structure Settlement Funding, Surgical Funding, Tractor Trailer or Semi Accident Funding, Prison Rape Case Funding, Wrongful Imprisonment Funding, Wrongful Termination Funding, Jones Act or Maritime Lawsuit Funding, Settled Case Settlement Funding, Slip and Fall or Premise Liability Case Funding, Wrongful Death or Personal Injury Lawsuit Funding, Defective Pain Pump Case Funding, Attorney or Law Firm Funding, Securities Fraud Arbitration Funding, Verdict on Appeal and Judgment on Appeal Cases, Commercial Litigation Funding, Qui Tam or Whistle Blower Lawsuit Funding, Zimmer Knee NexGen Case Funding, NFL Concussion Case Funding, Pradaxa Case Funding, Xarelto Case Funding, Morcellator Case Funding, GranuFlo Case Funding, Actos Case Funding, da Vinci Robot Case Funding, Byetta, Januvia, Victoza Diabetes Drug Case Funding, and all Civil Cases involving General Negligence that are represented by an Attorney.

Legal-Bay's programs are non-recourse lawsuit cash advances, also known as case funding. None of the programs should be considered to be a settlement loan, settlement loans, lawsuit loan, lawsuit loans, pre-settlement loans, or a pre-settlement loan. To learn more about Legal-Bay's Funding Process visit: http://www.lawsuitssettlementfunding.com/funding-process.php

To apply right now for pre-settlement lawsuit funding, which can be approved within 24 to 48 hours, feel free to contact Legal-Bay on the company's 24-hour hotline at: 877.571.0405 where live agents are available to assist you and answer any questions you may have. You may also fill out an online application to receive a free evaluation on your case at: http://lawsuitssettlementfunding.com

Legal-Bay LLC (as well as their related companies) is not a law firm and cannot provide legal advice on your case; however, Legal-Bay works with lawyers involved in mass tort litigations who can provide you with a free legal consultation at the consumer's direction.

Contact: Patty Kirby, COO/Head of Client Relations
             Ph. 877.571.0405 Email: [email protected]

SOURCE Legal-Bay LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.